logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Rocky Mountain Cancer Centers - Boulder

+13033852000
Source: Site record.
https://www.rockymountaincancercenters.com/locations/boulder

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Trial-derived.
243Total Trials
Source: Trial-derived.
15Recruiting Trials
Source: Trial-derived.
150Active Trials
Source: Trial-derived.
73Completed Trials
Source: Trial-derived.
957Unique Conditions
Source: Trial-derived.
73Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Invasive Breast Carcinoma (11)Source: Trial-derived. Stage IV Lung Cancer AJCC v8 (10)Source: Trial-derived. Breast Cancer (9)Source: Trial-derived. Malignant Solid Neoplasm (9)Source: Trial-derived. Recurrent Squamous Cell Lung Carcinoma (9)Source: Trial-derived. Chronic Lymphocytic Leukemia (8)Source: Trial-derived. Breast Carcinoma (7)Source: Trial-derived. Recurrent Lung Non-Small Cell Carcinoma (7)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (191)Source: Trial-derived. NRG Oncology (36)Source: Trial-derived. SWOG Cancer Research Network (36)Source: Trial-derived. Alliance for Clinical Trials in Oncology (32)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (24)Source: Trial-derived. Canadian Cancer Trials Group (9)Source: Trial-derived. Pfizer (9)Source: Trial-derived. Gilead Sciences (5)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Coordination with local labs / imaging
Source: AI-inferred. Remote informed consent

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Mammography
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Apheresis

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Electronic patient-reported outcome (ePRO) system
Source: AI-inferred. Electronic trial enrollment system